Nordson (NASDAQ:NDSN) Price Target Raised to $370.00

Nordson (NASDAQ:NDSN) had its price target boosted by analysts at Oppenheimer from $335.00 to $370.00 in a note issued to investors on Friday,Benzinga reports. The brokerage presently has an “outperform” rating on the industrial products company’s stock. Oppenheimer’s target price would indicate a potential upside of 10.55% from the stock’s current price.

NDSN has been the topic of several other reports. Weiss Ratings raised Nordson from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, June 29th. Robert W. Baird increased their target price on Nordson from $328.00 to $351.00 and gave the stock a “neutral” rating in a report on Friday. KeyCorp reaffirmed a “buy” rating on shares of Nordson in a report on Thursday. DA Davidson reissued a “buy” rating and issued a $345.00 target price on shares of Nordson in a research note on Thursday. Finally, Wall Street Zen downgraded Nordson from a “buy” rating to a “hold” rating in a research report on Saturday, June 27th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $326.57.

Nordson Trading Up 8.0%

Shares of NDSN opened at $334.70 on Friday. Nordson has a 12-month low of $219.60 and a 12-month high of $336.70. The firm has a market capitalization of $18.65 billion, a price-to-earnings ratio of 33.84, a P/E/G ratio of 2.06 and a beta of 0.96. The stock’s 50-day moving average price is $297.95 and its 200 day moving average price is $286.75. The company has a quick ratio of 1.65, a current ratio of 2.60 and a debt-to-equity ratio of 0.58.

Nordson (NASDAQ:NDSN) last announced its quarterly earnings data on Wednesday, August 19th. The industrial products company reported $3.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.09 by $0.16. Nordson had a net margin of 18.63% and a return on equity of 20.74%. The company had revenue of $817.67 million during the quarter, compared to analysts’ expectations of $779.49 million. During the same quarter in the prior year, the company posted $2.73 EPS. The business’s revenue was up 10.3% on a year-over-year basis. Nordson has set its FY 2026 guidance at 11.800-12.000 EPS. As a group, research analysts predict that Nordson will post 11.59 earnings per share for the current year.

Hedge Funds Weigh In On Nordson

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Clearstead Trust LLC acquired a new position in shares of Nordson during the second quarter worth about $25,000. Private Trust Co. NA grew its holdings in shares of Nordson by 70.8% during the fourth quarter. Private Trust Co. NA now owns 123 shares of the industrial products company’s stock worth $30,000 after buying an additional 51 shares in the last quarter. Keating Financial Advisory Services Inc. acquired a new stake in Nordson in the 2nd quarter valued at approximately $30,000. CYBER HORNET ETFs LLC acquired a new stake in Nordson in the 2nd quarter valued at approximately $31,000. Finally, N.E.W. Advisory Services LLC bought a new stake in Nordson in the 2nd quarter valued at approximately $33,000. 72.11% of the stock is owned by institutional investors and hedge funds.

Trending Headlines about Nordson

Here are the key news stories impacting Nordson this week:

• Positive Sentiment: Nordson reported quarterly sales of $817.7 million, up 10.3% year over year and ahead of the $779.5 million consensus estimate. Adjusted earnings of $3.25 per share also exceeded expectations of $3.09, while organic sales grew approximately 12% across all segments. Nordson Reports Record Third Quarter Results
• Positive Sentiment: Management raised fiscal 2026 guidance to $3.035 billion-$3.075 billion in sales and $11.80-$12.00 in adjusted EPS, above the roughly $11.59 analyst consensus. Backlog increased 35% year over year, supporting expectations for continued demand. Nordson Raises Fiscal 2026 Forecast
• Positive Sentiment: Advanced Technology Solutions led segment growth with a 28% increase, while Industrial Precision Solutions and Medical and Fluid Solutions each grew 5%, indicating broad-based operating momentum.
• Positive Sentiment: D.A. Davidson reaffirmed its Buy rating with a $345 price target, citing the earnings beat and higher guidance. D.A. Davidson Nordson Rating
• Neutral Sentiment: Robert W. Baird raised its price target from $328 to $351 but maintained a Neutral rating, suggesting analysts see additional upside while remaining cautious after the strong rally. The stock is trading close to its 52-week high, with a forward valuation that may limit further near-term gains.
• Neutral Sentiment: Nordson MEDICAL introduced its Divert ULTRA high-pressure stopcock product line for demanding medical applications, adding to the company’s medical-device offering, although the immediate financial impact is unclear. Nordson MEDICAL Divert ULTRA Launch
• Negative Sentiment: Recent insider activity has consisted entirely of sales, including sizable transactions by senior executives. While these sales may reflect diversification or scheduled transactions, they could temper investor sentiment.

Nordson Company Profile

Nordson Corporation designs, manufactures and markets precision dispensing equipment and systems that apply adhesives, coatings, sealants and polymers in a broad range of industrial and medical applications. The company’s portfolio spans fluid systems, curing and surface preparation technologies, vacuum and thermal management products, and advanced test and inspection solutions. Nordson’s offerings serve critical manufacturing processes by delivering exacting dispensing accuracy and process control to ensure consistent product performance and high production throughput.

Nordson operates through multiple segments that cater to diverse markets including electronics, packaging, medical, energy, automotive and general industrial sectors.